Technology | September 18, 2013

Simbionix Releases Endovascular Basic Skills Training Module

Simbionix, Endovascular Basic Skills Training Module, endovascular simulator

September 18, 2013 – Simbionix USA Corp. released the Endovascular Basic Skills training module for the ANGIO Mentor simulator. The Simbionix ANGIO Mentor is a virtual-reality training simulator that provides hands-on practice in a simulated environment for endovascular procedures. An expanding library of modules supports the acquisition and honing of procedural skills to build confidence and proficiency in various endovascular techniques and procedures.

The Endovascular Basic Skills module is intended for residents or fellows who wish to acquire essential wire-catheter and imaging skills. It is set in a game-like environment and will allow training in a user friendly, enjoyable and safe setting. It allows physicians to learn and practice on both non-anatomical and anatomical vascular models in an interactive and challenging setting. This module is relevant for the following disciplines: vascular surgery, interventional radiology, interventional cardiology, interventional neuroradiology, neuro surgery, cardiothoracic surgery and trauma.

"The basic skills module allows us to teach the essential technical skills required across all endovascular intervention practice without compromising patient safety. It enables the resident or fellow to train independently in his free time, repeating the task as necessary to improve his assessment results. The teaching physician can then use the data provided by the system to assess the trainee and generate his learning curve over time, as well as compare him to a cohort of his peers," stated Jean Bismuth, M.D., assistant professor and vascular surgeon at the Houston’s Methodist DeBakey Heart and Vascular Center.

For more information: simbionix.com

 

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...